|
🐜
|
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
10 auth.
A. Kakkar,
B. Brenner,
O. Dahl,
B. Eriksson,
P. Mouret,
J. Muntz,
...
A. Soglian,
Á. Pap,
F. Misselwitz,
S. Haas
|
10 |
2008 |
10
🐜
|
|
🐜
|
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
17 auth.
J. Neoptolemos,
J. Dunn,
D. Stocken,
J. Almond,
K. Link,
H. Beger,
C. Bassi,
M. Falconi,
P. Pederzoli,
C. Dervenis,
...
L. Fernández‐Cruz,
F. Lacaine,
Á. Pap,
D. Spooner,
D. Kerr,
H. Friess,
M. Büchler
|
10 |
2001 |
10
🐜
|
|
🐜
|
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
20 auth.
J. Weitz,
A. Lensing,
M. Prins,
R. Bauersachs,
J. Beyer-Westendorf,
H. Bounameaux,
T. Brighton,
A. Cohen,
B. Davidson,
H. Décousus,
...
M. S. Freitas,
G. Holberg,
Ajay Kakkar,
L. Haskell,
B. van Bellen,
Á. Pap,
S. Berkowitz,
P. Verhamme,
P. Wells,
P. Prandoni
|
9 |
2017 |
9
🐜
|
|
🐜
|
Rivaroxaban in Peripheral Artery Disease after Revascularization.
22 auth.
Marc P. Bonaca,
R. Bauersachs,
Sonia S Anand,
E. Debus,
M. Nehler,
M. Patel,
F. Fanelli,
W. Capell,
Lihong Diao,
Nicole Jaeger,
...
Connie N. Hess,
Á. Pap,
J. Kittelson,
I. Gudz,
L. Mátyás,
D. Krievins,
R. Diaz,
M. Brodmann,
E. Muehlhofer,
L. Haskell,
S. Berkowitz,
W. Hiatt
|
9 |
2020 |
9
🐜
|
|
🐜
|
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.
14 auth.
M. Prins,
A. Lensing,
T. Brighton,
R. Lyons,
Jeffrey Rehm,
Mila Trajanovic,
B. Davidson,
J. Beyer-Westendorf,
Á. Pap,
S. Berkowitz,
...
A. Cohen,
M. Kovacs,
P. Wells,
P. Prandoni
|
8 |
2014 |
8
🐜
|
|
🐜
|
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
39 auth.
C. Male,
A. Lensing,
J. Palumbo,
Riten Kumar,
I. Nurmeev,
Kerry M Hege,
D. Bonnet,
P. Connor,
H. L. Hooimeijer,
M. Torres,
Anthony K. C. Chan,
G. Kenet,
S. Holzhauer,
A. Santamaría,
P. Amedro,
...
E. Chalmers,
P. Simioni,
R. Bhat,
D. Yee,
O. Lvova,
J. Beyer-Westendorf,
T. Biss,
I. Martinelli,
P. Saracco,
M. Peters,
K. Kállay,
Cynthia A. Gauger,
M. Massicotte,
G. Young,
Á. Pap,
Madhurima Majumder,
William T. Smith,
J. Heubach,
S. Berkowitz,
K. Thelen,
D. Kubitza,
M. Crowther,
M. Prins,
P. Monagle
|
7 |
2019 |
7
🐜
|
|
🐜
|
Risk of recurrent venous thromboembolism according to baseline risk factor profiles.
18 auth.
M. Prins,
A. Lensing,
P. Prandoni,
P. Wells,
P. Verhamme,
J. Beyer-Westendorf,
R. Bauersachs,
H. Bounameaux,
T. Brighton,
A. Cohen,
...
B. Davidson,
H. Décousus,
A. Kakkar,
B. van Bellen,
Á. Pap,
M. Homering,
M. Tamm,
J. Weitz
|
6 |
2018 |
6
🐜
|
|
🐜
|
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization
19 auth.
W. Hiatt,
M. Bonaca,
M. Patel,
M. Nehler,
E. Debus,
Sonia S Anand,
W. Capell,
Taylor Brackin,
Nicole Jaeger,
Connie N. Hess,
...
Á. Pap,
S. Berkowitz,
E. Muehlhofer,
L. Haskell,
D. Brasil,
J. Madaric,
H. Sillesen,
D. Szalay,
R. Bauersachs
|
6 |
2020 |
6
🐜
|
|
🐜
|
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).
36 auth.
P. Connor,
M. Sánchez van Kammen,
A. Lensing,
E. Chalmers,
K. Kállay,
Kerry M Hege,
P. Simioni,
T. Biss,
F. Bajolle,
D. Bonnet,
S. Grunt,
Riten Kumar,
O. Lvova,
R. Bhat,
An Van Damme,
...
J. Palumbo,
A. Santamaría,
P. Saracco,
J. Payne,
S. Baird,
K. Godder,
V. Labarque,
C. Male,
I. Martinelli,
Michelle Morales Soto,
J. Motwani,
Sanjay Shah,
H. L. Hooimeijer,
M. Prins,
D. Kubitza,
William T. Smith,
S. Berkowitz,
Á. Pap,
Madhurima Majumder,
P. Monagle,
J. Coutinho
|
5 |
2020 |
5
🐜
|
|
🐜
|
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment
8 auth.
R. Bauersachs,
A. Lensing,
M. Prins,
D. Kubitza,
Á. Pap,
H. Décousus,
...
J. Beyer-Westendorf,
P. Prandoni
|
5 |
2014 |
5
🐜
|
|
🐜
|
Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis
12 auth.
Y. W. Cheung,
S. Middeldorp,
M. Prins,
Á. Pap,
A. Lensing,
A. T. ten Cate‐Hoek,
...
S. Villalta,
M. Milan,
J. Beyer-Westendorf,
P. Verhamme,
R. Bauersachs,
P. Prandoni
|
5 |
2016 |
5
🐜
|
